Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BuEAM Conditioning for ASCT in B Cell Lymphoma Except DLBCL
NCT01178645Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Jul 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of busulfan in B cell lymphoma, sponsored by Seoul National University Hospital. Primary endpoint: Progression-free survival at 3 years. Status: unknown.
02
Drugs
busulfan
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT01178645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01178645.